According to GAO's testimony, VHA has no oversight ensuring VAMCs check their inventory for and alert affected patients for recall products. Why is no oversight conducted to ensure this safety measure is carried out?
Editor's note · Context
Coffman questions the lack of oversight in patient safety regarding product recalls.
Share
More from Mike Coffman
I want to welcome everyone to the Military Personnel Subcommittee's hearing on 'Military Health System Reform: Pain Management, Opioids Prescription Management and Reporting Transparency.'
What we have seen in Ethiopia over the past few months has been entirely remarkable.
You have had very, very positive things and intuitive things that you have done for not only constituents in your district, but across the entire country.
this administration, the Trump administration, promised to clean up the culture of bureaucratic incompetence inside the VA. And based on this testimony today and other hearings we've had, I don't think they've made a lick of difference.





